Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1410 clinical trials
A Clinical Trail of Traditional Chinese Medicine Rehabilitation for Stroke Lead to Dysphagia / Cognitive Disorder

The traditional Chinese medicine rehabilitation for the deglutition and cognitive impairment after stroke will be intervened, which can promote the recovery of dysphagia and cognitive function of stroke patients, reduce the disability rate and improve the quality of life.

acupuncture
ischemic stroke
infarct
cerebral infarction
dysphagia
  • 0 views
  • 19 Feb, 2024
  • 1 location
2 march edit9  

Based on the Stage 1 analysis performed in November 2014, Arm 1 was chosen for expansion in Stage 2. Stage 2 dose will be 1-5x10xE8 transduced CART-19 cells. The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% …

  • 0 views
  • 26 Sep, 2024
  • 1 location
S0820, Adenoma and Second Primary Prevention Trial (PACES)

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing the event rate of adenomas and second primary colorectal cancers at three years in patients previously treated for stage 0 to III colon or rectal cancer.

  • 0 views
  • 02 Dec, 2024
  • 1 location
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

All patients in the study will get rituximab and lenalidomide. These are drugs that can be used to treat DLBCL.

large b-cell lymphoma
stem cell mobilization
brentuximab
lymphoma
stem cell transplantation
  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase I Study in Advanced Malignancies

RDT aims to take advantage of the relatively safer toxicity profiles of both lower dose radiation therapy and systemic ALA to treat non-superficial lesions in a manner similar to photodynamic therapy. The doses of radiation administered in this study will be lower than those typically used to treat cancer. However, …

neutrophil count
platelet transfusion
hair thinning
blood transfusion
alopecia
  • 0 views
  • 19 Feb, 2024
  • 1 location
SubsTRate OxidatioN in Girls

This study will examine race differences in total energy expenditure and respiratory quotient (RQ) during and after exercise, compared to a sedentary control condition, in adolescent girls who are classified as overweight. In addition, subjective appetite will be measured throughout the assessment periods.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Investigate the Pharmacokinetics Efficacy and Safety of INM005 in Patients With COVID-19.

Improvement of the clinical course 28 days after the start of treatment will be evaluated.

acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
  • 6 locations
The Influence of a Perturbation Training on Balance Recovery of Old Adults: a Randomized Controlled Trial

We hypothesize that response to an unexpected loss of balance is the balance responses will be improved in both training methods, but more in the random training method. We also hypothesize that brain function as seen in MRI will be improved in both training methods, more in the random training …

  • 0 views
  • 19 Feb, 2024
  • 3 locations
TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.

This study will evaluate the safety and effect of transcatheter arterial chemoembolization (TACE)combined with percutaneous transhepatic PD-1 knockout engineered T cell infusion in the Paitents with advanced hepatocellular carcinoma(HCC). Blood and tissue samples will also be collected for research purposes.

  • 0 views
  • 19 Feb, 2024
  • 1 location
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

New agents will be added aiming at improving survival outcome. Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,).

leukemia
rituximab
bortezomib injection
acute lymphoblastic leukemia
pediatric
  • 0 views
  • 19 Feb, 2024
  • 1 location